Advertisement Unichem selects PharmaSecure technology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Unichem selects PharmaSecure technology

Unichem Laboratories has purchased 70 million of PharmaSecure’s codes to be applied for use in protecting its brand and consumers against counterfeiting and diversion.

The unique identifier codes will be applied to several Unichem medicines, including Trika for the treatment of anxiety and Losar for the treatment of high blood pressure and hypertension.

The codes will be integrated into existing manufacturing processes at two plants in India.

The new product security solution empowers consumers to check whether a drug is authentic via text message (SMS) using a mobile phone.

When a consumer receives their medication, they are able to text the unique identifier on the individual strip to a phone number that is printed alongside the code.
The consumer then receives an authentication text message from Unichem in response.

The system ensures data protection and brand security to manufacturers for branded, branded generic and generic manufacturers through factory integration, Unichem said.

It also provides customized CRM services based on its authentication platform to enhanced consumer protection and improved health outcomes.

Unichem Laboratories chairman and MD Prakash Mody said strengthening their brand and differentiating products is an ongoing process of business operations and it is essential that they use the latest technology like the one PharmaSecure offers to protect the interests of customers.